-

06:13:32 AM

JNJ Stock News

JNJ - Johnson & Johnson

08/12/22 4:45 PM

NYSE : JNJ

Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science

Legal experts say the decision by Johnson & Johnson (NYSE: JNJ) to halt future sales and distribution of talc-based products worldwide, including its iconic

RHEA-AI

very negative

08/09/22 4:30 PM

NYSE : JNJ

conferences

Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Johnson& Johnson will participate in the Morgan Stanley 20 th Annual Global Healthcare Conference on Wednesday, September 14 th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m..

RHEA-AI

neutral

08/08/22 6:45 PM

NYSE : JNJ

Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson

Johnson& Johnson announced today that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and pursue other opportunities outside of the Company. Dr. Mammen joined Johnson& Johnson in 2017 as Global Head of Janssen R&D, and the Company thanks Dr. Mammen for his contributions in advancing Johnson& Johnson’ s...

RHEA-AI

neutral

08/08/22 7:30 AM

NYSE, Nasdaq : JNJ, AUTL

Pyramid Biosciences Names Nushmia Khokhar, MD, as Chief Medical Officer

Prior to joining Pyramid Biosciences, Dr. Khokhar served as Chief Medical Officer at Umoja Biopharma, a multi-platform, immuno-oncology company based in Seattle, WA. In this capacity, Dr. Khokhar oversaw Umoja’ s clinical development, operations, and regulatory functions. Prior to joining Umoja, Dr. Khokhar was the Senior Vice President& Head of Clinical...

RHEA-AI

positive

08/02/22 4:30 PM

NYSE : JNJ

conferences

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

Johnson& Johnson will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7 th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m.. This conference call will be available to investors and other...

RHEA-AI

neutral

07/19/22 6:25 AM

NYSE : JNJ

Johnson & Johnson Reports Q2 2022 Results

Johnson& Johnson today announced results for second-quarter 2022.“ Our solid second quarter results across Johnson& Johnson reflect the strength and resilience of our Company’ s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, Chief Executive Officer.“ I am continually energized by the focus and passion of my Johnson& Johnson...

RHEA-AI

neutral

07/18/22 9:20 AM

NYSE : JNJ

Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022

Johnson& Johnson today announced that Michael Ullmann will retire from his position as Executive Vice President, General Counsel at the end of this year, following 33 years of leadership and service to the Company. Throughout his distinguished career, Mr. Ullmann has worked with the organization’ s Board of Directors and partnered with four company CEOs to...

RHEA-AI

very positive

06/20/22 8:00 PM

NYSE : JNJ

Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research

The new Satellite Center will work to accelerate discovery research against flaviviruses, including dengue, which impacts 400 million people each yearThis effort will build on Johnson & Johnson's decade-long legacy and ongoing collaboration with Duke-NUS in early-stage dengue researchThe

RHEA-AI

neutral

06/08/22 8:00 AM

NYSE : JNJ

Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments

Johnson & Johnson (NYSE: JNJ) today published its 2021 Health for Humanity Report, which shares progress against its purpose-driven Health for Humanity 2025 Goals and serves as its annual disclosure on environmental, social and governance (ESG)

RHEA-AI

positive

05/12/22 4:30 PM

NYSE : JNJ

conferences

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16 th. Jennifer Taubert, Executive Vice President, Worldwide Chairman,

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next

JNJ Data

IndustryPharmaceutical Preparation Manufacturing
Websitewww.jnj.com
CeoAlex Gorsky
Security nameJohnson & Johnson
Issue typecs
SectorManufacturing
Sic code2834
Employees134500
Tags
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Address1 Johnson And Johnson Plz
StateNew Jersey
CityNew Brunswick
Zip08933-0001
CountryUS
Phone17325242455

About Johnson & Johnson

Johnson & Johnson believes good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, Johnson & Johnson has aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, Johnson & Johnson is committed to using its reach and size for good. Johnson & Johnson strives to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. Johnson & Johnson is blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.